Hsbc Holdings PLC Adaptive Biotechnologies Corp Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Hsbc Holdings PLC holds 36,111 shares of ADPT stock, worth $183,443. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,111

Previous 32,250 11.97%

Holding current value

$183,443

Previous $116,000 58.62%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.37 - $5.12 $13,011 - $19,768	3,861 Added 11.97%	36,111 $184,000
Q2 2024 Aug 12, 2024	SELL	$2.34 - $3.96 $3,664 - $6,201	-1,566 Reduced 4.63%	32,250 $116,000
Q1 2024 May 15, 2024	SELL	$2.88 - $4.8 $5,552 - $9,254	-1,928 Reduced 5.39%	33,816 $108,000
Q4 2023 Feb 12, 2024	SELL	$3.46 - $5.33 $4,480 - $6,902	-1,295 Reduced 3.5%	35,744 $175,000
Q3 2023 Nov 13, 2023	BUY	$5.07 - $8.44 $59,912 - $99,735	11,817 Added 46.85%	37,039 $201,000
Q2 2023 Aug 11, 2023	SELL	$6.19 - $8.78 $139,924 - $198,471	-22,605 Reduced 47.26%	25,222 $169,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $1,872 - $2,426	240 Added 0.5%	47,827 $422,000
Q4 2022 Feb 14, 2023	SELL	$6.26 - $9.34 $15,712 - $23,443	-2,510 Reduced 5.01%	47,587 $363,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $31,343 - $61,094	4,822 Added 10.65%	50,097 $366,000
Q2 2022 Aug 11, 2022	BUY	$6.4 - $14.73 $101,881 - $234,486	15,919 Added 54.23%	45,275 $358,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $297,082 - $848,388	29,356 New	29,356 $411,000
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $368,945 - $490,002	-12,290 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $221,029 - $305,887	6,860 Added 126.34%	12,290 $502,000
Q1 2021 May 14, 2021	SELL	$37.26 - $67.74 $36,701 - $66,723	-985 Reduced 15.35%	5,430 $218,000
Q4 2020 Feb 12, 2021	SELL	$45.01 - $65.47 $71,970 - $104,686	-1,599 Reduced 19.95%	6,415 $379,000
Q3 2020 Nov 12, 2020	BUY	$35.79 - $48.81 $286,821 - $391,163	8,014 New	8,014 $388,000

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $726M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Adaptive Biotechnologies Corp Transaction History